The American Journal of Medicine
Volume 120, Issue 10, Supplement 2 , Pages S13-S17, October 2007

Inferior Vena Cava Filters in the Management of Venous Thromboembolism

  • Mark A. Crowther, MD, MSc

      Affiliations

    • Corresponding Author InformationRequests for reprints should be addressed to Mark A. Crowther, MD, MSc, St Joseph’s Hospital, Room L208, 50 Charlton Avenue East, Hamilton, Ontario L8N 4A6, Canada.

Division of Hematology, McMaster University, Hamilton, Ontario, Canada

Abstract 

Inferior vena cava (IVC) filters, both retrievable and permanent, are indicated for the prevention of pulmonary embolism (PE) in patients contraindicated for anticoagulant therapy, in those with anticoagulant therapy complications, and perhaps for those with recurrent PE despite therapeutic anticoagulation. Because of the lack of randomized controlled trials (only 1 has been published), clinicians have little evidence-based information to assist them in determining proper use of IVC filters. The introduction of retrievable filters and the ease of insertion have stimulated increased use of these devices without strong evidence or follow-up to assess either efficacy or longer-term clinical outcomes. Current evidence-based guidelines recommend IVC filter insertion only in patients with proven venous thromboembolism and an absolute contraindication for anticoagulation.

Keywords: Deep vein thrombosis, Evidence based practice, Inferior vena caval filters, Pulmonary embolism, Recurrent thrombosis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Please see the Conflict of Interest section at the end of this article.

PII: S0002-9343(07)00667-5

doi:10.1016/j.amjmed.2007.07.015

The American Journal of Medicine
Volume 120, Issue 10, Supplement 2 , Pages S13-S17, October 2007